Market News / Story
Atrium Therapeutics Raises About $50 Million in PIPE at $7.93; Adds Pre-Funded Warrants
·
Atrium Therapeutics announced a private investment in public equity (PIPE) expected to raise approximately $50 million in gross proceeds. Under a Securities Purchase Agreement signed October 7, 2026, the company will sell 5,170,384 shares at $7.93 per share and 1,134,930 pre-funded warrants at $7.929 with a $0.001 exercise price, subject to a 9.99% (or 4.99%) ownership cap. Closing is anticipated on or about October 9, 2026. In connection with the financing, Atrium…
Related stories
Supertanker chartered from Gulf Coast to China for $76 million, 10 times higher than pre-war levelRead story summary
A supertanker was recently chartered to sail from the U.S. Gulf Coast to China for $76 million, a source familiar told CNBC, as shipping costs soar globally due to the crisis in the Middle East. The Alexandros was chartered by the trading firm Trafigura and is expected to load around Nov. 19, the source said. A normal rate for the route based on pre-war ...
VIEW SOURCE